For Holders Information - A Key competitor
Mauna Kea Technologies SA (MKEA-FR): Optical biopsies for increased diagnostic accuracy
Research Report
Latest valuation = A$160m ( Euro 4.10) - current market cap $A100m (Euro 2.60) - 25m shares on issue
https://www.bloomberg.com/press-rel...al-biopsies-for-increased-diagnostic-accuracy
In 2017 they sold 30 units of their flagship product Cellvizio.
2018 Quarterly Results
https://www.bloomberg.com/press-rel...technologies-reports-first-quarter-2018-sales
About Mauna Kea Technologies
Mauna Kea Technologies is a global medical device company focused on
eliminating uncertainties related to the diagnosis and treatment of cancer and
other diseases thanks to real time in vivo microscopic visualization. The
Company’s flagship product, Cellvizio, has received clearance to sell a wide
range of applications in more than 40 countries, including the United States,
Europe, Japan, China, Canada, Brazil and Mexico.
Ann: Market Update, page-44
Add OIL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
16.5¢ |
Change
0.010(6.45%) |
Mkt cap ! $129.4M | |||
| Open | High | Low | Value | Volume |
| 16.5¢ | 16.5¢ | 16.0¢ | $23.08K | 143.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 49548 | 16.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.5¢ | 73836 | 2 |
View Market Depth
| Last trade - 16.10pm 29/11/2024 (20 minute delay) ? |
| OIL (ASX) Chart |
